Forest to pay $164M for various violations

Share this article:
A federal judge has sentenced Forest Pharmaceuticals to pay a criminal fine of $150 million and forfeit $14 million in assets for its guilty plea last November to felony and misdemeanor charges. These involved obstructing an FDA regulatory inspection, distributing Levothroid when it was an unapproved new drug, and illegally promoting Celexa for use in children and adolescents.
The Justice Department says the sentencing was the final component of a global resolution totaling more than $313 million to resolve criminal and civil allegations against Forest.
In September 2010, Forest Laboratories and Forest Pharmaceuticals entered a civil settlement to resolve False Claims Act charges involving Levothroid, Celexa and Lexapro. As part of the civil settlement, Forest agreed to pay over $149 million, including more than $88 million to the federal government and more than $60 million to states.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"